VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

EHA 2020 | The evolving CLL treatment paradigm

Carsten Niemann, MD, PhD, of Copenhagen University Hospital, Copenhagen, Denmark, highlights novel targeted therapies in development for chronic lymphocytic leukemia (CLL), the movement of the field over the past decade and the application of combining targeted therapies to improve patient outcomes. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter